CDC https://www.cdc.gov has awarded global consulting and digital services provider ICF a $31 million contract to support CDC’s Nationwide Syndromic Surveillance Platform called BioSense. The platform will enable local, state, and national health officials to monitor and respond to the harmful health effects.
BioSense has been used during the COVID-19 pandemic to continuously monitor outbreak patterns and trends and alert health officials concerning hot spots as they emerge. ICF will use BioSense to work with CDC’s Division of Health Informatics and Surveillance and partners to improve syndromic surveillance efficacy and coverage, provide national platform sustainability, provide partner and community outreach, and for analytic capabilities.
CDC also awarded ICF three recompete contracts with a combined value of $35 million to provide digital transformation, health surveillance, data management, technical assistance and communications services.
The contract agreements included:
- A $15 million task order with CDC’s Division of HIV Prevention’s Data Coordinating Centers to centralize and modernize two of their largest HIV behavioral clinical surveillance systems
- A $11 million task order with CDC’s Division of Cancer Prevention and Controls’ National Program of Cancer Registries (NPCR) to provide data collection, monitoring, and analytical and evaluation support to the Cancer Surveillance System
- A $9 million task order with the Office on Smoking and Health to provide communications, marketing, and partnership engagement services as well as research and technical assistance support on issues related to tobacco control
Mark Lee, ICF Executive VP said, “ICF looks forward to continuing to help CDC advance the critical public health missions of their programs.”